EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanostructured lipid carriers in Rheumatoid Arthritis: treatment, advancements and applications

Swarnika Sharma, Rashmi Ghosh, Arockia Babu Marianesan, Sumaya Hussain, Jai Deo Pandey, Manish Kumar

Inflammopharmacology · 2025-03 · 33 (3) · 941-958

DOI: 10.1007/s10787-025-01669-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 02.03.2025. Verfasst von Swarnika Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hari College of Pharmacy, Malhipur Road Jandheri, Saharanpur, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Nanostructures, Drug Carriers, Lipids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects the joints and causes pain, swelling, and deformity. Current treatments, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs, often have limited efficacy and adverse side effects. Nanostructured lipid carriers (NLCs) are promising drug delivery agents for treating RA. NLCs are comprised of solid and liquid lipids, forming a nanostructured matrix that enhances drug solubility, stability, and controlled release. They offer advantages over traditional carriers such as improved skin penetration, increased bioavailability, and reduced systemic side effects. Topical NLC formulations show improved stability and skin absorption, targeting drugs specifically to the affected joints, thus reducing the required dose and systemic exposure. Studies on NLCs for delivering anti-inflammatory and antirheumatic drugs, such as methotrexate, indomethacin, and curcumin, in RA animal models indicate the potential for improved therapeutic efficacy and safety. NLCs represent a promising approach for targeted RA drug delivery, offering better efficacy, fewer side effects, and higher patient compliance. However, further research is needed to optimize NLC formulations and evaluate their clinical efficacy and safety in RA patients. The development of NLC-based drug delivery systems for RA treatment may lead to more effective and well-tolerated therapies, thereby improving the quality of life of patients with this debilitating disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidNanostructuresDrug CarriersLipidsAntirheumatic AgentsHumansAnimalsDrug Delivery SystemsAnti-Inflammatory Agents, Non-SteroidalSkin Absorption

Stichwörter der Autor:innen

BioavailabilityNanostructured lipid carriers (NLCs)Rheumatoid arthritisSkin penetrationTargeted delivery

Substanzen

Drug CarriersLipidsAntirheumatic AgentsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Hari College of Pharmacy, Malhipur Road Jandheri, Saharanpur, Uttar Pradesh, India.
  • Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, Punjab, 142001, India.
  • Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, 281406, India.
  • College of Pharmacy,, Stephens Group of Institutions, Jammu, 181102, Jammu and Kashmir, India.
  • Rajarshi Rananjay Sinh College of Pharmacy, Maharaja Bhawan Baksh Singh Nagar, Amethi, Uttar Pradesh, 227405, India.
  • Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, Punjab, 142001, India. manish_singh17@rediffmail.com.

Zitieren

APA

Sharma, S., Ghosh, R., Marianesan, A. B., Hussain, S., Pandey, J. D., & Kumar, M. (2025). Nanostructured lipid carriers in Rheumatoid Arthritis: treatment, advancements and applications. Inflammopharmacology, 33(3), 941-958. https://doi.org/10.1007/s10787-025-01669-2

Vancouver

Sharma S, Ghosh R, Marianesan AB, Hussain S, Pandey JD, Kumar M. Nanostructured lipid carriers in Rheumatoid Arthritis: treatment, advancements and applications. Inflammopharmacology. 2025;33(3):941-958. doi:10.1007/s10787-025-01669-2

BibTeX
@article{Sharma2025,
  author = {Sharma, Swarnika and Ghosh, Rashmi and Marianesan, Arockia Babu and Hussain, Sumaya and Pandey, Jai Deo and Kumar, Manish},
  title = {Nanostructured lipid carriers in Rheumatoid Arthritis: treatment, advancements and applications},
  journal = {Inflammopharmacology},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {941--958},
  doi = {10.1007/s10787-025-01669-2}
}
Kostenlos starten →